This HTML5 document contains 44 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04329/identifier/pdb/
n14http://linked.opendata.cz/resource/drugbank/drug/DB04329/identifier/kegg-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04329/identifier/pubchem-compound/
n10http://bio2rdf.org/drugbank:
n6http://linked.opendata.cz/resource/drugbank/drug/DB04329/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB04329/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB04329/identifier/chebi/

Statements

Subject Item
n2:DB04329
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n10:DB04329 n12:DB04329
dcterms:title
Isoquinoline
adms:identifier
n6:46507258 n7:ISQ n8:8405 n13:DB04329 n14:C06323 n15:16092
n3:synthesisReference
Choong S. Kim, Nam J. Lee, Joong H. Kim, "Process for the production of (.+-.)-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isoquinoline derivatives." U.S. Patent US4497952, issued November, 1967.
n3:IUPAC-Name
n4:271B5025-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B502B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B502A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5027-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5028-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5029-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B503A-363D-11E5-9242-09173F13E4C5 n4:271B5023-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5021-363D-11E5-9242-09173F13E4C5 n4:271B5024-363D-11E5-9242-09173F13E4C5 n4:271B503D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B503E-363D-11E5-9242-09173F13E4C5 n4:271B5022-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B503F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5031-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5032-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B502C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B502D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B502F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B502E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5030-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
119-65-3
n3:Bioavailability
n4:271B5036-363D-11E5-9242-09173F13E4C5
n3:Boiling-Point
n4:271B503C-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5038-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5039-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B503B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5035-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5034-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5037-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5026-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5033-363D-11E5-9242-09173F13E4C5